Williams David A, Baum Christopher
Division of Experimental Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Science. 2003 Oct 17;302(5644):400-1. doi: 10.1126/science.1091258.
The successful use of retroviral gene transfer to treat 10 patients with X-linked severe combined immunodeficiency (SCID-X1) has been welcomed as evidence of the therapeutic potential of gene therapy. However, as Williams and Baum suggest in their Perspective, the discovery that 2 of the 10 patients developed leukemia within 3 years of gene therapy (Hacein-Bey-Abina et al.) reinforces the need to develop even more specific gene therapy interventions.
逆转录病毒基因转移成功用于治疗10名X连锁重症联合免疫缺陷病(SCID-X1)患者,这一成果受到广泛欢迎,被视为基因治疗具有治疗潜力的证据。然而,正如威廉姆斯和鲍姆在他们的《观点》文章中所指出的,10名患者中有2名在基因治疗后3年内患上白血病(哈辛-贝-阿比纳等人的研究),这一发现凸显了开发更具针对性的基因治疗干预措施的必要性。